Skip to main content
. 2023 Oct 27;5(11):e0993. doi: 10.1097/CCE.0000000000000993

TABLE 3.

Mixed-Effect Model for Vasopressor Requirementa

Initial Model Final Model
Predictors Coefficient p Coefficient p
Day of therapy −0.001 < 0.0001 −0.002 0.0002
Current day Sequential Organ Failure Assessment 0.008 < 0.0001 −0.007 < 0.0001
Fludrocortisoneb 0.159 0.0055
Hydrocortisoneb 0.0004 < 0.0001 0.0003 < 0.0001
Renal replacement therapyc 0.020 < 0.0001
Type of infectiond −0.004 0.24
100% T>MICc −0.006 0.0318
100% T>4×MICc 0.002 0.38

T>MIC and T>4×MIC = time the free beta-lactam concentration was above the minimum inhibitory concentration or four multiples of the minimum inhibitory concentration, respectively.

a

Vasopressors requirement was evaluated as norepinephrine-equivalent dose based on µg/kg/min.

b

Per 1 mg/d.

c

Yes compared with no.

d

Blood vs. pneumonia.Values in boldface font are p < 0.05.